FDA Clearance Tracker · K183090
Relieva Tract Balloon Dilation System
Last checked: Nov 19, 2026Latest source record: Apr 19, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Apr 19, 2019
Substantially Equivalent
Time to decision
164 days
Received Nov 6, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class I
The decision
- FDA number
- K183090
- Device name
- Relieva Tract Balloon Dilation System
- Applicant
- Acclarent, Inc.
- Applicant location
- Irvin, CA
- Received
- Nov 6, 2018
- Decided
- Apr 19, 2019
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Balloon, Nasal Airway (QGK)
- Device class
- Class I
- Regulation
- 21 CFR 874.4420
- Specialty
- Otolaryngology (ENT)
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code QGK (Balloon, Nasal Airway).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K183090
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Acclarent, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K253612 · Decided Feb 19, 2026 · 93 days after receipt
Device type: Eustachian Tube Balloon Dilation Device (PNZ) · Otolaryngology (ENT)
K230742 · Decided Dec 13, 2023 · 271 days after receipt
Device type: Eustachian Tube Balloon Dilation Device (PNZ) · Otolaryngology (ENT)
K231862 · Decided Jul 21, 2023 · 28 days after receipt
Device type: Ear, Nose, And Throat Stereotaxic Instrument (PGW) · Neurology & Neurosurgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.